Furthermore, BRCA1 mutations were strongly associated with hormone-receptor negative status in previous analyses of high-risk breast-ovarian cancer families whereas most BRCA2-mutated tumours do not have a TNBC phenotype [34]–[38]. The gene discussed is BRCA1; the disease is neoplasm.